首頁‎ > ‎未命名‎ > ‎

2017.12

張貼者:2017年12月16日 下午4:39Service Center   [ 已更新 2018年1月24日 上午12:02 ]
碁米庫斯生技所開發的產品「抗生素的測試及篩選平台」已被美國知名製藥公司Entasis Therapeutics用來研發新抗生素,Entasis對此產品的評註如下: “The library of genetically engineered K. pneumoniae mutants made by KeMyth Biotech represent important new tools for antibacterial research as they enable rapid insights into mechanisms of uptake and efflux in this problematic pathogen.  Our research team at Entasis is currently using them routinely in our discovery efforts and is grateful that this important resource has been made available to the general community.”   Alita Miller, Head of Bioscience, Entasis Therapeutics

Comments